Trending...
- Armadillos with Benefits™ - PicPocket-Labs, Inc. details its plans/roadmap at SxSW for combining "location-based NFTs" and loyalty programs
- Suburban Bliss - Sue Barr's Art Exhibition Celebrates Everyday Superstars
- CEG Expands Critical Power Service Offering to Include Industrial Generator Maintenance
NEPTUNE, N.J., March 15, 2023 ~ Investigators from Hackensack Meridian Jersey Shore University Medical Center were part of an international study that showed removing just the part of a lung containing an early-stage lung cancer was as effective as taking out an entire lung lobe, without putting patients at greater risk of a recurrence or poor survival. The findings of the clinical trial, published in the February 9, 2023, issue of the New England Journal of Medicine, could change the standard of care for some people with small cancers in the outer areas of the lung (periphery) that have not spread.
Dr. Thomas Bauer, chairman of surgery at Hackensack Meridian Jersey Shore University Medical Center and one of the study's lead authors, said: "The results of this clinical trial are very important and may change the way we manage early-stage lung cancer. We also witnessed a trend toward better breathing ability in patients who had less lung tissue removed, which could be especially beneficial for people with reduced respiratory function."
More on Jersey Desk
The study randomly assigned 697 patients with peripheral stage 1 non-small cell lung cancer (NSCLC) to undergo either lobectomy (357 patients) or sublobar resection (340 patients). All patients had tumors that were 2 cm or less in size and had not spread to the lymph nodes ("node-negative"). After a median follow-up of 7 years, the rate of recurrence and overall survival were similar between the two groups. Five years later, the rate of recurrence was 64.1% after lobectomy and 63.6% after sublobar resection; 5-year overall survival was 78.9% and 80.3%, respectively.
Patients in the sublobar resection group had forced expiratory volume rates (a measure of lung function) that were 2 percentage points better than those who underwent lobectomy. Forced vital capacity, another measure of breathing ability, was also slightly better for those who underwent sublobar resection.
The authors concluded that sublobar resection is an effective treatment for people with stage 1 node-negative NSCLC and small tumors. They added that these findings will become increasingly relevant as more people are screened for early-stage lung cancer and more older patients with early-stage disease opt for sublobar resection as their preferred surgery option.
For information about thoracic surgery services at Jersey Shore University Medical Center, visit www.hackensackmeridianhealth.org/en/Services/Surgical-Services/Thoracic-Surgery.
Dr. Thomas Bauer, chairman of surgery at Hackensack Meridian Jersey Shore University Medical Center and one of the study's lead authors, said: "The results of this clinical trial are very important and may change the way we manage early-stage lung cancer. We also witnessed a trend toward better breathing ability in patients who had less lung tissue removed, which could be especially beneficial for people with reduced respiratory function."
More on Jersey Desk
- Women in Business Host Southern Ocean Chamber April 28
- Aquia Inc. Joins the AWS Partner Network and the AWS Public Sector Partner Program
- Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing
- Databloom's Blossom Achieves Faster and More Efficient Big Data Analytics
- Orchard Audio's New PecanPi®+ DAC and Streamer Feature AKM's Latest Flagship Chips
The study randomly assigned 697 patients with peripheral stage 1 non-small cell lung cancer (NSCLC) to undergo either lobectomy (357 patients) or sublobar resection (340 patients). All patients had tumors that were 2 cm or less in size and had not spread to the lymph nodes ("node-negative"). After a median follow-up of 7 years, the rate of recurrence and overall survival were similar between the two groups. Five years later, the rate of recurrence was 64.1% after lobectomy and 63.6% after sublobar resection; 5-year overall survival was 78.9% and 80.3%, respectively.
Patients in the sublobar resection group had forced expiratory volume rates (a measure of lung function) that were 2 percentage points better than those who underwent lobectomy. Forced vital capacity, another measure of breathing ability, was also slightly better for those who underwent sublobar resection.
The authors concluded that sublobar resection is an effective treatment for people with stage 1 node-negative NSCLC and small tumors. They added that these findings will become increasingly relevant as more people are screened for early-stage lung cancer and more older patients with early-stage disease opt for sublobar resection as their preferred surgery option.
For information about thoracic surgery services at Jersey Shore University Medical Center, visit www.hackensackmeridianhealth.org/en/Services/Surgical-Services/Thoracic-Surgery.
Filed Under: Business
0 Comments
Latest on Jersey Desk
- The In-N-Out Burger Financial Planning Story
- Horizon BCBS NJ Updates Bariatric Surgery Criteria to Include Patients with BMI Over 30 &Type 2 Di
- Pillar College to Launch Online Master's Degree Program in Spanish
- Cash Depot Appoints Tony Gaines as Chief Revenue Officer and Brand Ambassador
- Sip Social Co. Partners With Apé Canada For Supply Of Piaggio Apé's
- Corner Property Management welcomes Lawrence N. Sauer to their team as Director of Client Services
- Employees at New Jersey's Valley Wellness Medical Marijuana Dispensary Welcome Spring by Voting to Unionize With UFCW
- BayView Entertainment Enters into an Agreement to Acquire Distributor Passion River Films
- Eddie Turner is Recognized as the #9 Motivational Speaker in the World By Global Gurus!
- RE/MAX Signature Earns Top Regional Award
- Suburban Bliss - Sue Barr's Art Exhibition Celebrates Everyday Superstars
- CEG Expands Critical Power Service Offering to Include Industrial Generator Maintenance
- NPPG Acquires Oriental's Retirement Plan Record Keeping and Third-Party Administration Services
- Wohler releases out-of-band configuration tools for Riedel 2110 SFP's
- Levinger Regens Announces New Initiative to Improve Hydrogen Carbon Intensity
- Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
- Expert tip: Private Jet Engine Maintenance Program - Pros and Cons for Preowned Jet Buyers
- Divorce Court 101: 5 Simple Rules and Tips
- The Bunny Hop 5K Fun Run & Walk will be held on April 2, 2023 in Manahawkin!
- Gaming and entertainment company Spinrack Corporation, appoints Jesse Norton as Chief Marketing Officer